A preliminary investigation into the effects of doxazosin on cognitive functioning in tobacco-deprived and -satiated smokers.
Walter RobertsTerril L VerplaetseKelly E MooreLindsay M OberleitnerSherry A McKeePublished in: Human psychopharmacology (2019)
Doxazosin reduced symptoms of tobacco withdrawal according to self-report and cognitive assessment and improved inhibitory control above predrug levels. This research identifies potential mechanisms by which doxazosin might improve smoking outcomes.